Integrated Biopharma Inc financial data

Symbol
INBP on OTC
Industry
Pharmaceutical Preparations
Location
225 Long Avenue, Building 15, Hillside, NJ
State of incorporation
Delaware
Fiscal year end
June 30
Former names
INTEGRATED HEALTH TECHNOLOGIES INC (to 4/16/2003), CHEM INTERNATIONAL INC (to 5/14/2002)
Latest financial report
10-Q - Q1 2024 - May 10, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 292 % -3.18%
Quick Ratio 185 % -3.23%
Debt-to-equity 39.2 % -26.8%
Return On Equity -0.62 % -106%
Return On Assets -0.44 % -108%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 30.1M shares +0.56%
Common Stock, Shares, Outstanding 30.1M shares +0.5%
Entity Public Float 3.26M USD -64.4%
Common Stock, Value, Issued 60K USD 0%
Weighted Average Number of Shares Outstanding, Basic 30.1M shares +0.5%
Weighted Average Number of Shares Outstanding, Diluted 30.8M shares -2.22%

Income Statement

Label TTM Value / Value Unit Change %
Operating Income (Loss) -72K USD -115%
Nonoperating Income (Expense) 9K USD -250%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -63K USD -115%
Income Tax Expense (Benefit) 53K USD +123%
Net Income (Loss) Attributable to Parent -116K USD -108%
Earnings Per Share, Basic 0 USD/shares -100%
Earnings Per Share, Diluted 0.01 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.02M USD -20.1%
Accounts Receivable, after Allowance for Credit Loss, Current 4.72M USD +0.77%
Inventory, Net 11.2M USD +12.4%
Other Assets, Current 353K USD -1.67%
Assets, Current 18.3M USD +4.3%
Deferred Income Tax Assets, Net 4.71M USD -0.9%
Property, Plant and Equipment, Net 1.89M USD +10%
Operating Lease, Right-of-Use Asset 2.02M USD -28.8%
Assets 26.9M USD +0.23%
Accounts Payable, Current 3.67M USD +3.96%
Liabilities, Current 6.95M USD +12.7%
Operating Lease, Liability, Noncurrent 1.09M USD -44.6%
Liabilities 8.03M USD -1.33%
Retained Earnings (Accumulated Deficit) -32.5M USD -0.36%
Stockholders' Equity Attributable to Parent 18.9M USD +100807%
Liabilities and Equity 26.9M USD +0.23%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.31M USD +32.4%
Net Cash Provided by (Used in) Financing Activities 3K USD
Net Cash Provided by (Used in) Investing Activities -38K USD +24%
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 30.1M shares +0.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.28M USD +52.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 10K USD -9.09%
Deferred Tax Assets, Valuation Allowance 1.44M USD +25.8%
Depreciation 316K USD -11.2%
Payments to Acquire Property, Plant, and Equipment 38K USD -24%
Property, Plant and Equipment, Gross 9.81M USD +4.25%
Operating Lease, Liability, Current 935K USD +6.49%
Deferred Income Tax Expense (Benefit) 8K USD -78.4%
Deferred Tax Assets, Operating Loss Carryforwards 5.11M USD -1.18%
Deferred Federal Income Tax Expense (Benefit) 81K USD +800%
Operating Lease, Payments 265K USD +16.2%
Additional Paid in Capital 51.4M USD +0.56%
Depreciation, Depletion and Amortization 77K USD -12.5%
Share-based Payment Arrangement, Expense 49K USD -47.9%
Deferred State and Local Income Tax Expense (Benefit) -14K USD -167%
Interest Expense 30K USD -25%